Published in Medical Letter on the CDC and FDA, January 8th, 2006
The litigation concerns Teva's application to market an extended-release venlafaxine capsule product.
Wyeth markets extended-release venlafaxine under the trade name Effexor XR.
Wyeth and Teva will now file motions with the court requesting that the court approve the settlement and enter related orders.
This article was prepared by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.